Fox Chase Cancer Center Welcomes Khadijah A. Mitchell

Dr. Mitchell
Fox Chase Cancer Center is pleased to announce the hiring of Khadijah A. Mitchell, PhD, MS, as an Assistant Professor in the Cancer Prevention and Control Research Program.

PHILADELPHIA (August 11, 2023) — Fox Chase Cancer Center is pleased to announce the hiring of Khadijah A. Mitchell, PhD, MS, as an Assistant Professor in the Cancer Prevention and Control Research Program.

A national leader in health equity and inclusive teaching, Mitchell’s research focuses on cancer health disparities. Her work has identified racial differences in lung cancer, furthering prevention and precision medicine based on environmental, behavioral, and biological factors.

Most recently, Mitchell was an Assistant Professor of biology at Lafayette College, where she was named the Peter C.S. d’Aubermont, MD, Endowed Scholar of Health and Life Sciences and received the Faculty All Star Award. She has received numerous other honors and awards, including the NIH Fellows Award for Research Excellence.

She earned her doctorate in human genetics and molecular biology from the Johns Hopkins University School of Medicine and completed postdoctoral fellowships at Lafayette and the National Cancer Institute.

Mitchell’s research has been published in numerous peer-reviewed journals, including Nature Communications and Nature Cancer, and she has presented her work at many conferences, including the American Association for Cancer Research.

She has been a nationally sought-after speaker on health equity, including serving as a subject matter expert on health disparities for the American Lung Association and the LUNGevity Foundation. She has also helped guide government policy, including advising the Pennsylvania Department of Health.

Mitchell is a member of the American Association for Cancer Research and the Pennsylvania Cancer Coalition.

She began her tenure at Fox Chase on July 1.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427